BCR | Biochemical recurrence |
CT | Computed tomography |
EMA | European Medicines Agency |
FDA | US Food and Drug Administration |
mCRPC | Metastatic castration-resistant prostate cancer |
MRI | Magnetic resonance imaging |
NIR | Near-infrared |
PCa | Prostate cancer |
PET | Positron emission tomography |
pCLE | Probe-based confocal laser endomicroscopy |
PSM | Positive surgical margin |
PSMA | Prostate-specific membrane antigen |